United States

Analyst Research Report Snapshot


BTG plc






09 Oct 2012





Companies referenced:


Available for Immediate Download

BTG plc Company Profile is the essential source for top-level company data and information. BTG plc Company Profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. BTG is an international healthcare company, which is engaged in providing pharmaceuticals and interventional medicine pharmaceuticals. The company's products include antidotes to treat toxicity associated with medicines used for heart conditions and cancer, treatment for snakebites, and interventional oncology products that are used to treat patients with liver or prostate tumors. BTG is also involved in the licensing of novel pharmaceuticals. The company operates in North America, Europe, and Australia. It is headquartered in London, the UK and employs around 550 people. The company recorded revenues of £197 million (approximately $314.6 million) in the fiscal year ended March 2012, an increase of 76.8% over 2011. The company's operating profit was £19.9 million (approximately $31.8 million) in fiscal 2012, as compared to an operating loss of £13.8 million (approximately $22 million) in 2011. Its net profit was £14.6 million (approximately $23.3 million) in fiscal 2012, an increase of 58.7% over 2011. Scope of the Report - Provides all the crucial information on BTG plc required for business and competitor intelligence needs -Data is supplemented with details on BTG plc history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from BTG plc Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Understand prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.